Ocular Therapeutix Inc’s recent filing unveils that its insider Dugel Pravin unloaded Company’s shares for reported $0.15 million on Feb 24 ’25. In the deal valued at $6.87 per share,21,475 shares were sold. As a result of this transaction, Dugel Pravin now holds 3,520,318 shares worth roughly $26.23 million.
Then, Heier Jeffrey S. sold 3,061 shares, generating $21,029 in total proceeds. Upon selling the shares at $6.87, the Chief Scientific Officer now owns 265,998 shares.
Before that, Kaiser Peter sold 3,009 shares. Ocular Therapeutix Inc shares valued at $20,672 were divested by the Chief Development Officer at a price of $6.87 per share. As a result of the transaction, Kaiser Peter now holds 210,078 shares, worth roughly $1.57 million.
RBC Capital Mkts initiated its Ocular Therapeutix Inc [OCUL] rating to an Outperform in a research note published on March 18, 2025; the price target was $17. A number of analysts have revised their coverage, including Needham’s analysts, who began to cover the stock in mid March with a ‘”a Buy”‘ rating. Scotiabank began covering OCUL with “Sector outperform” recommendation on October 16, 2024. TD Cowen revised its rating on June 20, 2024. It rated OCUL as “a Buy” which previously was an “a Hold”.
Price Performance Review of OCUL
On Tuesday, Ocular Therapeutix Inc [NASDAQ:OCUL] saw its stock fall -6.17% to $7.45. Over the last five days, the stock has lost -12.46%. Ocular Therapeutix Inc shares have fallen nearly -12.76% since the year began. Nevertheless, the stocks have fallen -19.55% over the past one year. While a 52-week high of $11.77 was reached on 01/07/25, a 52-week low of $4.06 was recorded on 03/04/25. SMA at 50 days reached $7.69, while 200 days put it at $8.33.
Levels Of Support And Resistance For OCUL Stock
The 24-hour chart illustrates a support level at 7.18, which if violated will result in even more drops to 6.90. On the upside, there is a resistance level at 7.99. A further resistance level may holdings at 8.52. The Relative Strength Index (RSI) on the 14-day chart is 48.70, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.27, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 46.89%. Stochastics %K at 61.19% indicates the stock is a holding.
How much short interest is there in Ocular Therapeutix Inc?
A steep rise in short interest was recorded in Ocular Therapeutix Inc stocks on 2025-02-28, growing by 1.18 million shares to a total of 12.05 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 10.87 million shares. There was a rise of 9.76%, which implies that there is a positive sentiment for the stock.
